Literature DB >> 10989457

Ras-induced cellular events (review).

V Ayllón1, A Rebollo.   

Abstract

Ras is a crucial regulator of cell growth in eukaryotic cells. Activated Ras can stimulate signal transduction cascades, leading to cell proliferation, differentiation or apoptosis. It is also one of the most commonly mutated genes in both solid tumours and haematologic neoplasias. In leukaemia and tumours, aberrant Ras signalling can be induced directly by Ras mutation or indirectly by altering genes that associate with Ras or its signalling pathways. A requisite for Ras function is localization to the plasma membrane, which is induced by the post-translational modification farnesylation. Molecules that interfere with this Ras modification have been used as antitumour agents. Ras is emerging as a dual regulator of cell functions, playing either positive or negative roles in the control of proliferation or apoptosis. The diversity of Ras-mediated effects may be related in part to the differential involvement of Ras homologues in distinct cellular processes or to the expanding array of Ras effectors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10989457     DOI: 10.1080/09687680050117093

Source DB:  PubMed          Journal:  Mol Membr Biol        ISSN: 0968-7688            Impact factor:   2.857


  13 in total

Review 1.  Evolving therapies: farnesyltransferase inhibitors.

Authors:  W Thomas Purcell; Ross C Donehower
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

2.  Antagonistic pleiotropy for life-history traits at the gene expression level.

Authors:  Zoltán Bochdanovits; Gerdien de Jong
Journal:  Proc Biol Sci       Date:  2004-02-07       Impact factor: 5.349

3.  Border forces and friction control epithelial closure dynamics.

Authors:  Olivier Cochet-Escartin; Jonas Ranft; Pascal Silberzan; Philippe Marcq
Journal:  Biophys J       Date:  2014-01-07       Impact factor: 4.033

4.  Activation of sterile20-like kinase 1 in proteasome inhibitor bortezomib-induced apoptosis in oncogenic K-ras-transformed cells.

Authors:  Fuminori Teraishi; Wei Guo; Lidong Zhang; Fengqing Dong; John J Davis; Takehiko Sasazuki; Senji Shirasawa; Jinsong Liu; Bingliang Fang
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Differential sensitization of different prostate cancer cells to apoptosis.

Authors:  Jinjin Guo; Tongbo Zhu; Lihua Chen; Takashi Nishioka; Takanori Tsuji; Zhi-Xiong J Xiao; Chang Yan Chen
Journal:  Genes Cancer       Date:  2010-08

6.  Identification of a small GTPase inhibitor using a high-throughput flow cytometry bead-based multiplex assay.

Authors:  Zurab Surviladze; Anna Waller; Yang Wu; Elsa Romero; Bruce S Edwards; Angela Wandinger-Ness; Larry A Sklar
Journal:  J Biomol Screen       Date:  2009-12-11

7.  RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.

Authors:  Won-Il Kim; Ilze Matise; Miechaleen D Diers; David A Largaespada
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

8.  Molecular docking and analysis of survivin delta-ex3 isoform protein.

Authors:  Z Ezziane
Journal:  Open Med Chem J       Date:  2008-03-27

9.  Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12.

Authors:  Jon D Shuman; Thomas Sebastian; Philipp Kaldis; Terry D Copeland; Songyun Zhu; Robert C Smart; Peter F Johnson
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 10.  ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy.

Authors:  Kimberly Mayes; Zhijun Qiu; Aiman Alhazmi; Joseph W Landry
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.